Possible mechanism and current recommendation of thromboembolism in COVID-19

Dita Aulia Rachmi; Eka Prasetya Budi Mulia; Johanes Nugroho

doi:10.3889/oamjms.2020.4900

Possible mechanism and current recommendation of thromboembolism in COVID-19

Dita Aulia Rachmi, Eka Prasetya Budi Mulia, Johanes Nugroho

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.

Original language	English
Pages (from-to)	66-74
Number of pages	9
Journal	Open Access Macedonian Journal of Medical Sciences
Volume	8
Issue number	T1
DOIs	https://doi.org/10.3889/oamjms.2020.4900
Publication status	Published - 15 Jun 2020
Externally published	Yes

Keywords

Anticoagulation
COVID-19
Thrombosis
Venous thromboembolism

Access to Document

10.3889/oamjms.2020.4900

Cite this

@article{25acfb628be042219d0a031f21cc4881,

title = "Possible mechanism and current recommendation of thromboembolism in COVID-19",

abstract = "The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.",

keywords = "Anticoagulation, COVID-19, Thrombosis, Venous thromboembolism",

author = "Rachmi, {Dita Aulia} and Mulia, {Eka Prasetya Budi} and Johanes Nugroho",

note = "Publisher Copyright: {\textcopyright} 2020 Dita Aulia Rachmi, Eka Prasetya Budi Mulia, Johanes Nugroho.",

year = "2020",

month = jun,

day = "15",

doi = "10.3889/oamjms.2020.4900",

language = "English",

volume = "8",

pages = "66--74",

journal = "Open Access Macedonian Journal of Medical Sciences",

issn = "1857-5749",

publisher = "Open Access Macedonian Journal of Medical Sciences",

number = "T1",

}

TY - JOUR

T1 - Possible mechanism and current recommendation of thromboembolism in COVID-19

AU - Rachmi, Dita Aulia

AU - Mulia, Eka Prasetya Budi

AU - Nugroho, Johanes

PY - 2020/6/15

Y1 - 2020/6/15

N2 - The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.

AB - The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.

KW - Anticoagulation

KW - COVID-19

KW - Thrombosis

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85089375303&partnerID=8YFLogxK

U2 - 10.3889/oamjms.2020.4900

DO - 10.3889/oamjms.2020.4900

M3 - Article

AN - SCOPUS:85089375303

SN - 1857-5749

VL - 8

SP - 66

EP - 74

JO - Open Access Macedonian Journal of Medical Sciences

JF - Open Access Macedonian Journal of Medical Sciences

IS - T1

ER -

Possible mechanism and current recommendation of thromboembolism in COVID-19

Abstract

Keywords

Access to Document

Fingerprint

Cite this